# A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer

> **NCT00735826** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Aerodigestive Tract Cancer
- Lung Cancer
- Esophageal Cancer
- Head and Neck Cancer

## Interventions

- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT00735826
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735826, "A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00735826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*